Mitral regurgitation after myocardial infarction: A review

Francesca Bursi, Maurice E Sarano, Steven J. Jacobsen, Veronique Lee Roger

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

Mitral regurgitation after myocardial infarction is the result of multifactorial processes involving local and global left ventricular remodeling. The prevalence of mitral regurgitation varies from 11% to 59%. Published studies differ greatly in design, inclusion criteria, duration of follow-up, and technique of mitral regurgitation assessment. However, they consistently indicate that mitral regurgitation after myocardial infarction carries an adverse prognosis with increased risk of death and heart failure independently of previously known indicators of risk after myocardial infarction. Mitral regurgitation is often clinically silent; therefore, it should be systematically evaluated by echocardiography. Standard color Doppler imaging is a highly sensitive method to detect even mild degrees of ischemic mitral regurgitation. One unique advantage of echocardiography is that it accurately quantifies the severity of mitral regurgitation by measuring the effective regurgitant orifice area and the regurgitant volume using Doppler methodology. Therefore, the evaluation should include precise quantification of the degree of mitral regurgitation to best appraise the ensuing risk. Current medical options rely chiefly on angiotensin converting enzyme-inhibitors and beta-blocker therapy, and surgical approaches offer future promise. Both categories of therapeutic approaches should be evaluated by randomized controlled trials.

Original languageEnglish (US)
Pages (from-to)103-112
Number of pages10
JournalAmerican Journal of Medicine
Volume119
Issue number2
DOIs
StatePublished - Feb 2006

Fingerprint

Mitral Valve Insufficiency
Myocardial Infarction
Echocardiography
Ventricular Remodeling
Angiotensin-Converting Enzyme Inhibitors
Randomized Controlled Trials
Heart Failure
Color
Therapeutics

Keywords

  • Mechanism
  • Mitral regurgitation
  • Myocardial infarction
  • Prevalence
  • Prognosis

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Mitral regurgitation after myocardial infarction : A review. / Bursi, Francesca; Sarano, Maurice E; Jacobsen, Steven J.; Roger, Veronique Lee.

In: American Journal of Medicine, Vol. 119, No. 2, 02.2006, p. 103-112.

Research output: Contribution to journalArticle

@article{4aa6fb24f0db4c97ac3b93d72e05a213,
title = "Mitral regurgitation after myocardial infarction: A review",
abstract = "Mitral regurgitation after myocardial infarction is the result of multifactorial processes involving local and global left ventricular remodeling. The prevalence of mitral regurgitation varies from 11{\%} to 59{\%}. Published studies differ greatly in design, inclusion criteria, duration of follow-up, and technique of mitral regurgitation assessment. However, they consistently indicate that mitral regurgitation after myocardial infarction carries an adverse prognosis with increased risk of death and heart failure independently of previously known indicators of risk after myocardial infarction. Mitral regurgitation is often clinically silent; therefore, it should be systematically evaluated by echocardiography. Standard color Doppler imaging is a highly sensitive method to detect even mild degrees of ischemic mitral regurgitation. One unique advantage of echocardiography is that it accurately quantifies the severity of mitral regurgitation by measuring the effective regurgitant orifice area and the regurgitant volume using Doppler methodology. Therefore, the evaluation should include precise quantification of the degree of mitral regurgitation to best appraise the ensuing risk. Current medical options rely chiefly on angiotensin converting enzyme-inhibitors and beta-blocker therapy, and surgical approaches offer future promise. Both categories of therapeutic approaches should be evaluated by randomized controlled trials.",
keywords = "Mechanism, Mitral regurgitation, Myocardial infarction, Prevalence, Prognosis",
author = "Francesca Bursi and Sarano, {Maurice E} and Jacobsen, {Steven J.} and Roger, {Veronique Lee}",
year = "2006",
month = "2",
doi = "10.1016/j.amjmed.2005.08.025",
language = "English (US)",
volume = "119",
pages = "103--112",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Mitral regurgitation after myocardial infarction

T2 - A review

AU - Bursi, Francesca

AU - Sarano, Maurice E

AU - Jacobsen, Steven J.

AU - Roger, Veronique Lee

PY - 2006/2

Y1 - 2006/2

N2 - Mitral regurgitation after myocardial infarction is the result of multifactorial processes involving local and global left ventricular remodeling. The prevalence of mitral regurgitation varies from 11% to 59%. Published studies differ greatly in design, inclusion criteria, duration of follow-up, and technique of mitral regurgitation assessment. However, they consistently indicate that mitral regurgitation after myocardial infarction carries an adverse prognosis with increased risk of death and heart failure independently of previously known indicators of risk after myocardial infarction. Mitral regurgitation is often clinically silent; therefore, it should be systematically evaluated by echocardiography. Standard color Doppler imaging is a highly sensitive method to detect even mild degrees of ischemic mitral regurgitation. One unique advantage of echocardiography is that it accurately quantifies the severity of mitral regurgitation by measuring the effective regurgitant orifice area and the regurgitant volume using Doppler methodology. Therefore, the evaluation should include precise quantification of the degree of mitral regurgitation to best appraise the ensuing risk. Current medical options rely chiefly on angiotensin converting enzyme-inhibitors and beta-blocker therapy, and surgical approaches offer future promise. Both categories of therapeutic approaches should be evaluated by randomized controlled trials.

AB - Mitral regurgitation after myocardial infarction is the result of multifactorial processes involving local and global left ventricular remodeling. The prevalence of mitral regurgitation varies from 11% to 59%. Published studies differ greatly in design, inclusion criteria, duration of follow-up, and technique of mitral regurgitation assessment. However, they consistently indicate that mitral regurgitation after myocardial infarction carries an adverse prognosis with increased risk of death and heart failure independently of previously known indicators of risk after myocardial infarction. Mitral regurgitation is often clinically silent; therefore, it should be systematically evaluated by echocardiography. Standard color Doppler imaging is a highly sensitive method to detect even mild degrees of ischemic mitral regurgitation. One unique advantage of echocardiography is that it accurately quantifies the severity of mitral regurgitation by measuring the effective regurgitant orifice area and the regurgitant volume using Doppler methodology. Therefore, the evaluation should include precise quantification of the degree of mitral regurgitation to best appraise the ensuing risk. Current medical options rely chiefly on angiotensin converting enzyme-inhibitors and beta-blocker therapy, and surgical approaches offer future promise. Both categories of therapeutic approaches should be evaluated by randomized controlled trials.

KW - Mechanism

KW - Mitral regurgitation

KW - Myocardial infarction

KW - Prevalence

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=31444456955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31444456955&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2005.08.025

DO - 10.1016/j.amjmed.2005.08.025

M3 - Article

C2 - 16443408

AN - SCOPUS:31444456955

VL - 119

SP - 103

EP - 112

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 2

ER -